<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Anti-prothrombin (anti-PT) antibodies are recently identified antibodies directed toward a <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-binding protein (prothrombin), which deserve attention for the reported clinical and pathogenic relevance in <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> and <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="1" pm="."><plain>We have recently carried out a longitudinal study on the predictive value of anti-PT antibodies in SLE showing that they have a higher diagnostic accuracy for <z:mp ids='MP_0005048'>thrombosis</z:mp> than anti-beta(2)-GPI and anticardiolipin antibodies, and, along with LAC activity, are the best predictors of <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> in SLE patients </plain></SENT>
</text></document>